An AI tool accurately detected structural heart disease from smartwatch single-lead ECGs in a 600-person prospective trial.
Key Details
- 1AI model was trained using 266,000 12-lead ECGs from 110,000 patients and validated on large external cohorts.
- 2Prospective real-world testing was performed with 600 adults using smartwatch-recorded single-lead ECGs.
- 3Algorithm achieved 88% accuracy (AUC) in smartwatch data; sensitivity was 86% and negative predictive value 99%.
- 4Diseases detected included weakened pumping, valve damage, or thickened heart muscle—most commonly found with cardiac ultrasound (echo).
- 5Preliminary results were presented at AHA Scientific Sessions 2025 and have not yet been peer-reviewed.
Why It Matters
Wearable devices leveraging AI may democratize early detection of serious heart conditions, traditionally requiring advanced imaging. This signals a potential paradigm shift in accessible screening workflows, informing radiology and cardiology practice.
Source
EurekAlert
Related News
•EurekAlert
AI Outperforms Radiologists in Pancreatic Cancer Detection on CT Scans
An international study finds that AI surpasses average radiologists in detecting pancreatic cancer on CT scans using a newly developed benchmark and dataset.
•EurekAlert
AI Simplifies CT Reports, Boosting Cancer Patients' Understanding
AI-driven text simplification significantly improves cancer patients' comprehension of CT scan reports.
•EurekAlert
AI Decision Support Proves Helpful, Yet Contentious, in Emergency Medicine
Researchers found that AI-driven decision support improved correct decision rates among emergency care doctors, but physician acceptance of AI recommendations remains split.